Awards to the Institution

Award Value
Early Translational IV: John Griffin Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin $630,269
Total:
$630,269.00
Icon for xls export